CORRESP 1 filename1.htm

lxrp_corresp.htm

January 28, 2025

VIA EDGAR AND FACSIMILE

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Re: Lexaria Bioscience Corp. (the “Company”) Registration Statement on Form S-3 File No. 333-284407

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time on January 30, 2025, or as soon thereafter as is practicable.

If you have any questions, please call Avital Perlman, Esq. at (212) 930-9700.

	Very truly yours,
	LEXARIA BIOSCIENCE CORP.
	By:	/s/ Richard Christopher
	Name:	Richard Christopher
	Title:	Chief Executive Officer